Building Medical Affairs as a Strategic Partner in Clinical Development

Medical Affairs teams are uniquely positioned to be the ‘strategic conveners’ of all stakeholders to help strategically guide the clinical development pathway from trial conception through pre-commercialization preparation.

By the end of this webinar, attendees will learn…

1. The benefits of early Medical Engagement in the trial design process, including protocol development, patient voice (e.g., advocacy engagement, patient ad boards, DE&I), and site selection
2. How Medical Affairs teams can help to accelerate study execution via Clinical Trial Liaisons, Research Science Liaisons, and investigator and patient engagement
3. The role of Medical Affairs in translating clinical insights/relationships into value for Commercial teams via pre-commercialization strategies and market preparation

This webinar will provide the Medical Affairs community with a differentiated and bold view to drive the future state of Medical Affairs and what “good” looks like regarding the role of Medical Affairs in Clinical Development.

Moderator:

Colin Oliver

Senior Managing Director, Global Medical Affairs & HEOR

Syneos Health

Speaker:

Gissoo DeCotiis

Global Head of Advocacy & Strategic Relations, Global Medical Affairs, Oncology

Daiichi Sanyko

Speaker:

Everest Nwakamma

Sr director, Global Oncology MSL Excellence

Daiichi Sankyo

Speaker:

Patrick Nealon

Senior Vice President Clinical Development Operations

Aura Biosciences

Speaker:

Meredith Wilson

SVP, Patient Advocacy

Syneos Health